KemPharm Inc (KMPH):企業の財務・戦略的SWOT分析

◆英語タイトル:KemPharm Inc (KMPH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH193165FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥66,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥99,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
KemPharm Inc (KemPharm) is a clinical-stage specialty pharmaceutical company that offers discovery and development of proprietary new molecular entity prodrugs. The company’s product pipeline includes KP415, KP484 methylphenidate drug for the treatment of attention deficit hyperactivity disorder (ADHD); and KP879 drugs for the treatment of stimulant use disorder. KemPharm uses ligand activated therapy (LAT) a platform technology to produce new molecular entity prodrugs. The company offers its products in the therapeutic areas such as Attention deficit hyperactivity disorder (ADHD), pain, and other central nervous system indications. KemPharm is headquartered in Florida, the US.

KemPharm Inc Key Recent Developments

Mar 11,2021: KemPharm Reports Fourth Quarter and Full-Year 2020 Financial Results
Mar 09,2021: KemPharm to Report Fourth Quarter and Full Year 2020 Financial Results
Mar 04,2021: KemPharm to present at the 33rd Annual Roth Conference
Jan 08,2021: KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market
Nov 23,2020: KemPharm provides update on development pipeline

This comprehensive SWOT profile of KemPharm Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of KemPharm Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

KemPharm Inc – Key Information
KemPharm Inc – Overview
KemPharm Inc – Key Employees
KemPharm Inc – Key Employee Biographies
KemPharm Inc – Key Operational Heads
KemPharm Inc – Major Products and Services
KemPharm Inc – History
KemPharm Inc – Company Statement
KemPharm Inc – Locations And Subsidiaries
KemPharm Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

KemPharm Inc – Business Description
KemPharm Inc – Corporate Strategy
KemPharm Inc – SWOT Analysis
SWOT Analysis – Overview
KemPharm Inc – Strengths
KemPharm Inc – Weaknesses
KemPharm Inc – Opportunities
KemPharm Inc – Threats
KemPharm Inc – Key Competitors

Section 3 – Company Financial Performance Charts

KemPharm Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

KemPharm Inc, Key Information
KemPharm Inc, Key Ratios
KemPharm Inc, Share Data
KemPharm Inc, Major Products and Services
KemPharm Inc, History
KemPharm Inc, Key Employees
KemPharm Inc, Key Employee Biographies
KemPharm Inc, Key Operational Heads
KemPharm Inc, Other Locations
KemPharm Inc, Subsidiaries
KemPharm Inc, Key Competitors
KemPharm Inc, SWOT Analysis
KemPharm Inc, Ratios based on current share price
KemPharm Inc, Annual Ratios
KemPharm Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[KemPharm Inc (KMPH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Evotec AG (EVT)-医療機器分野:企業M&A・提携分析
    Summary Evotec AG (Evotec) is a drug discovery alliance and development partnership company. It identifies and develops small molecule drugs across various therapeutic areas such as, cancer, neurological and nephrological conditions, cardiovascular, inflammation, pain, metabolic and respiratory dise …
  • Liechtensteinische Landesbank AG:企業の戦略・SWOT・財務情報
    Liechtensteinische Landesbank AG - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • BioPorto Diagnostics AS:医療機器:M&Aディール及び事業提携情報
    Summary BioPorto Diagnostics AS (BioPorto Diagnostics), formerly AntibodyShop AS is an in-vitro diagnostics company that manufactures and markets antibodies and antibody based products. The company’s products include matched reagent set, immunoassays, antigens, antibodies, controls calibrators and m …
  • TreeHouse Foods Inc:企業の戦略・SWOT・財務分析
    TreeHouse Foods Inc - Strategy, SWOT and Corporate Finance Report Summary TreeHouse Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • WPX Energy Inc (WPX):企業の財務・戦略的SWOT分析
    WPX Energy Inc (WPX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • BOE Technology Group Co Ltd:企業の戦略・SWOT・財務情報
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Synthos SA:企業の戦略的SWOT分析
    Synthos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • BASF Corp:企業の戦略的SWOT分析
    BASF Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • XTL Biopharmaceuticals Ltd (XTLB):企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • Factor Therapeutics Ltd (FTT):企業の財務・戦略的SWOT分析
    Summary Factor Therapeutics Ltd (FTL), formerly Tissue Therapies Ltd, is a developer of wound care therapeutics. The company develops treatments for acute and chronic wound healing applications such as chronic skin ulcers and burns. Its lead therapeutic candidate, VF-001 is a targeted growth factor …
  • AA PLC:企業の戦略・SWOT・財務情報
    AA PLC - Strategy, SWOT and Corporate Finance Report Summary AA PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • McKesson Corporation:企業の戦略・SWOT・財務情報
    McKesson Corporation - Strategy, SWOT and Corporate Finance Report Summary McKesson Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • The Norwegian Radium Hospital Research Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary The Norwegian Radium Hospital Research Foundation (Radium Hospital) is a research center that conducts research programs and clinical studies. The center invests in oncology, novel therapeutics and diagnostics. It operates as a hub for cancer and oncology treatment research. Radium Hospital …
  • Elbit Imaging Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Elbit Imaging Ltd (Elbit), formerly Elbit Medical Imaging Ltd is a diversified company that operates through various business segments including commercial centers, hotel, medical industries and devices, and plots in India. The company’s commercial centers segment includes initiation, constr …
  • Pierrel Spa (PRL)-製薬・医療分野:企業M&A・提携分析
    Summary Pierrel Spa (Pierrel) is a pharmaceutical company that offers contract services to biopharmaceutical and life sciences industries across the world. The company offers services in the areas of contract research, discovery of medicinal product candidates, clinical research and contract manufac …
  • Medidata Solutions Inc (MDSO)-医療機器分野:企業M&A・提携分析
    Summary Medidata Solutions Inc (Medidata) is a provider of cloud based solutions for life sciences sectors. It offers wide range of advanced tools for data & analytics, planning, data capture, study management, monitoring, payments, and platform services. The company offers technology and data analy …
  • TripAdvisor Inc:企業の戦略・SWOT・財務分析
    TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report Summary TripAdvisor Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Weir Group Plc (WEIR):石油・ガス:M&Aディール及び事業提携情報
    Summary The Weir Group Plc (Weir Group) is a provider of engineering solutions. The company designs and manufactures highly engineered products and services for minerals, oil and gas, and power industries. Its products and service portfolio include pressure pumping equipment, pressure control produc …
  • Somnomed Ltd (SOM)-医療機器分野:企業M&A・提携分析
    Summary Somnomed Ltd (SomnoMed) is medical device company that develops produces, commercializes and sells device for the oral treatment of sleep related disorders. The company’s products include somnodent, an oral appliance for obstructive sleep apnea; and somnobrux, a mouthguard that protects pati …
  • Ionian Hotel Enterprises S.A.:企業の戦略・SWOT・財務分析
    Ionian Hotel Enterprises S.A. - Strategy, SWOT and Corporate Finance Report Summary Ionian Hotel Enterprises S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆